Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 31-45 of 183
The Future of MS Management: Novel Agents and Clinical Approaches
NeuroFrontiersThe Future of MS Management: Novel Agents and Clinical Approaches
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
NeuroFrontiersPregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
NeuroFrontiersReevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
NeuroFrontiersRecognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiersModern MS Care: Navigating Treatment Options for Better Patient Outcomes
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiersEpigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- advertisement
Understanding MS: Managing Hidden and Overlooked Symptoms
NeuroFrontiersUnderstanding MS: Managing Hidden and Overlooked Symptoms
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
NeuroFrontiersAdvancing MS Care: Evolving Treatments and High-Efficacy Approaches
Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
NeuroFrontiersRecognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiersASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiersSafety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiersNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
- advertisement
Reevaluating Spinal Muscular Atrophy Therapy: Signs, Tools, and Strategies
NeuroFrontiersReevaluating Spinal Muscular Atrophy Therapy: Signs, Tools, and Strategies
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
NeuroFrontiersRestoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiersEarly Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
